CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma

NCT05458180 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T-cell Lymphoma

Interventions

DRUG: Lposomal mitoxantrone hydrochloride,Cyclophosphamide,Vincristine,Etoposide and Prednisone(CMOEP)

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]